doi:10.3390/molecules26030703 Yadav H, Lee J-H, Lloyd J, Walter P, Rane SG
We compared 24,221 type 2 diabetic patients prescribed semaglutide, 49,266 patients prescribed liraglutide, and 45,153 patients prescribed dulaglutide to 551,119 type 2 diabetic patients prescribed insulin to determine whether there were differences in the risk of thyroid cancer in each group
It has shown promise in promoting weight loss and improving blood sugar control in clinical trials
To ensure safety, we align with recommendations from Dietary Guidelines for Americans, the American Medical Association, and the American Heart Association
By exploring the potential mental health considerations surrounding these medications, we aim to empower you to navigate this journey with transparency and a deep respect for your autonomy